NasdaqCM - Nasdaq Real Time Price USD
ImmuCell Corporation (ICCC)
5.37
-0.13
(-2.36%)
As of 1:02:43 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
357.90
357.90
--
-1,543.87
954.17
Investing Cash Flow
-461.23
-461.23
--
-3,964.27
-1,597.36
Financing Cash Flow
2,882.81
2,882.81
--
1,114.24
3,878.72
End Cash Position
3,758.23
3,758.23
--
5,791.56
10,185.47
Income Tax Paid Supplemental Data
7.29
7.29
--
4.92
5.11
Interest Paid Supplemental Data
528.91
528.91
--
338.52
308.68
Capital Expenditure
-465.73
-465.73
--
-3,975.27
-2,608.65
Issuance of Capital Stock
4,648.02
4,648.02
--
--
4,233.03
Issuance of Debt
--
--
--
2,000
400
Repayment of Debt
-1,468.34
-1,468.34
--
-897.13
-768.27
Free Cash Flow
-107.82
-107.82
--
-5,519.15
-1,654.48
12/31/2021 - 5/5/1987
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CSBR Champions Oncology, Inc.
7.96
+1.14%
MLECW Moolec Science SA
0.0170
-11.92%
LIXT Lixte Biotechnology Holdings, Inc.
1.2800
-2.29%
NRXS NeurAxis, Inc.
2.3700
-1.94%
RADX Radiopharm Theranostics Limited
4.1750
+3.09%
GYRE Gyre Therapeutics, Inc.
9.13
-0.65%
CSCI COSCIENS Biopharma Inc.
3.1500
0.00%
GHRS GH Research PLC
9.33
-1.79%
LVTX LAVA Therapeutics N.V.
1.3402
-2.18%
XBIT XBiotech Inc.
2.9700
-5.98%